| I-44 Nathalie Perdaems Multi-species translational PK/PD modelling in type 2 diabetes Wednesday 10:30-12:00 |
| II-01 Nina Scherer A population pharmacokinetic (PK) model of metformin regarding immediate and extended release formulations under fasted and fed conditions Wednesday 15:10-16:30 |
| II-39 Pavan Vaddady A Comprehensive Model-Based Meta-Analysis (MBMA) of Diabetes Studies in Type 2 Diabetes Mellitus Patients to Quantify the Relationship between HbA1c and Fasting Plasma Glucose Wednesday 15:10-16:30 |
| II-42 Michiel Van Esdonk Quantifying the growth hormone lowering effect of BIM23B065 after a GH stimulation test Wednesday 15:10-16:30 |
| II-48 Veronika Voronova Evaluation of immediate release exenatide effects on gastric motility and intestinal glucose absorption using a systems pharmacology model Wednesday 15:10-16:30 |
| II-53 Gustaf Wellhagen Impact of genotype assumption in a semi-mechanistic PK model of metformin Wednesday 15:10-16:30 |
| III-67 Jennifer Leohr A Semi-Physiologic Model of Postprandial Triglyceride Response following Anti-Obesity Therapy Thursday 09:50-11:20 |
| IV-23 Roberto Bizzotto A model of insulin kinetics describing tests with various insulin secretion and infusion patterns by means of a consistent mechanism Thursday 14:45-16:15 |
| IV-65 Christiane Dings Mathematical modeling of glucose, insulin and c-peptide during the OGTT in pre-diabetic subjects: A DIRECT study Thursday 14:45-16:15 |
